To test this hypothesis, we examined fatty acid levels in three clinical groups; our CH population, into a group with normal Aβ42 and T-tau ratio (CH-NAT) and a second group with pathological Aβ42/T-tau ratio (CH-PAT) similar to AD subjects. The gene discussed is BRD2; the disease is Alzheimer disease.